Human induced pluripotent stem cells (hiPSCs) are considered a promising tool in medicine, with the potential to unlock treatments for many health conditions such as neurodegenerative diseases and ...

LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...

Officials at Mytos, which is automating cell manufacturing, launched its automated contract development and manufacturing organization (CDMO), offering to overcome one of what they call regenerative ...

With the power of robotics and the personalized medicine expertise of one of Japan's top drugmakers, Astellas Pharma and Yaskawa Electric Corporation are setting off on a joint venture to help ...

Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection ...

Human leukocyte antigen (HLA) genotyping is critical when preparing for stem cell transplants. The procedure is crucial to determine the genetic compatibility of the HLAs between the donor and ...

The production of red blood cells from stem cells has emerged as a transformative approach to address chronic blood shortages and meet the increasing demand for transfusion therapies. By harnessing ...

Funding supports safety studies, manufacturing and clinical planning needed before applying to test the treatment in patients ...

Stem cells can fight disease from the inside out. But not all treatments are created equal. By Mohana Ravindranath The promise of stem cell therapy is powerful. Scientists can draw versatile cells ...